MT will soon be in the US, and as discussed, hopefully one of the meetings is with the Michael J Fox Foundation, funding research into Parkinson's Disease. Parkinson's Disease is one of the neurodegenerative disease's nominated in recent presentations as a possible target to commence pre-clinical work - obviously a decent grant would help the decision making process.
I was this looking at the list of grants recently awarded by the foundation, and came across this little ripper.
There is plenty of scientific literature on the impact of autophagy on Parkinson's Disease.
But just imagine if there was an Autophagy-lysosome biomarker in Parkinson's Disease.
Identify the issue very early on in the disease using an autophagy biomarker.
Hey presto, get the patient onto Monepantel ASAP.
Have a look at this piece of research funded by the foundation.
- Forums
- ASX - By Stock
- The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
MT will soon be in the US, and as discussed, hopefully one of...
-
- There are more pages in this discussion • 367 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NUZ (ASX) to my watchlist
(20min delay)
|
|||||
Last
19.5¢ |
Change
-0.005(2.50%) |
Mkt cap ! $94.89M |
Open | High | Low | Value | Volume |
20.0¢ | 20.3¢ | 19.5¢ | $124.5K | 628.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 2791 | 19.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.0¢ | 62424 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 2791 | 0.195 |
9 | 239472 | 0.190 |
5 | 341026 | 0.185 |
6 | 354777 | 0.180 |
4 | 120797 | 0.175 |
Price($) | Vol. | No. |
---|---|---|
0.200 | 62424 | 2 |
0.205 | 4800 | 1 |
0.210 | 82780 | 3 |
0.215 | 206338 | 3 |
0.225 | 34130 | 2 |
Last trade - 15.39pm 01/11/2024 (20 minute delay) ? |
Featured News
NUZ (ASX) Chart |